ME01453B - Čvrste farmaceutske kompozicije koje sadrže valsartan - Google Patents

Čvrste farmaceutske kompozicije koje sadrže valsartan

Info

Publication number: ME01453B
Authority: ME; Montenegro
Prior art keywords: valsartan; pharmaceutical composition; solid pharmaceutical; solid; composition
Prior art date: 2004-12-24

Application number

MEP-2012-149A

Other languages

English (en)

Inventor

Miha Vrbinc

Vovk Janika Slanc

Marija Rangus

Silvo Zupancic

Franci Bevec

Lidija Cernosa

Original Assignee

Krka Tovarna Zdravil D D Novo Mesto

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-24

Filing date

2005-12-23

Publication date

2014-04-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35966966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01453(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-24 Priority claimed from EP04030782A external-priority patent/EP1674080A1/en

2005-12-23 Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto

2014-04-20 Publication of ME01453B publication Critical patent/ME01453B/me

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

MEP-2012-149A 2004-12-24 2005-12-23 Čvrste farmaceutske kompozicije koje sadrže valsartan ME01453B (me)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP04030782A EP1674080A1 (en)	2004-12-24	2004-12-24	Solid pharmaceutical composition comprising valsartan
EP05004433		2005-03-01
PCT/EP2005/013963 WO2006066961A1 (en)	2004-12-24	2005-12-23	Solid pharmaceutical composition comprising valsartan
EP08165631A EP2033629B1 (en)	2004-12-24	2005-12-23	Solid pharmaceutical composition comprising valsartan

Publications (1)

Publication Number	Publication Date
ME01453B true ME01453B (me)	2014-04-20

Family

ID=35966966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2012-149A ME01453B (me)	2004-12-24	2005-12-23	Čvrste farmaceutske kompozicije koje sadrže valsartan

Country Status (16)

Country	Link
US (1)	US20080102120A1 (me)
EP (2)	EP2033629B1 (me)
CN (1)	CN101087589B (me)
AU (1)	AU2005318365B2 (me)
CA (1)	CA2592091A1 (me)
DK (1)	DK2033629T3 (me)
EA (2)	EA015108B1 (me)
ES (1)	ES2397552T3 (me)
HR (1)	HRP20130033T1 (me)
ME (1)	ME01453B (me)
NO (1)	NO20073889L (me)
PL (1)	PL2033629T3 (me)
PT (1)	PT2033629E (me)
RS (1)	RS52607B (me)
SI (1)	SI2033629T1 (me)
WO (1)	WO2006066961A1 (me)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
WO2008076780A2 (en) *	2006-12-14	2008-06-26	Isp Investments Inc.	Amorphous valsartan and the production thereof
TR200703568A1 (tr) *	2007-05-24	2008-07-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Valsartan formülasyonları
GB0715628D0 (en) *	2007-08-10	2007-09-19	Generics Uk Ltd	Solid valsartan composition
WO2009113091A2 (en) *	2008-01-24	2009-09-17	Usv Limited	Pharmaceutical compositions comprising valsartan
EP2405899A2 (en) *	2009-03-11	2012-01-18	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
EP2536396B1 (en)	2010-02-16	2016-08-10	KRKA, D.D., Novo Mesto	Process for the preparation of oral solid dosage forms comprising valsartan
CN102119912A (zh) *	2011-01-25	2011-07-13	南京白敬宇制药有限责任公司	一种非水溶性药物缓释制剂的制备方法
CN102204907A (zh) *	2011-03-31	2011-10-05	北京赛科药业有限责任公司	一种含缬沙坦的药物组合物及其制备方法
WO2013098576A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan
WO2013098578A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
CN103599084B (zh) *	2013-11-22	2018-10-30	威海迪素制药有限公司	一种降压组合物
KR101545268B1 (ko) *	2015-02-05	2015-08-20	보령제약 주식회사	정제 및 이의 제조방법
CN104887640B (zh) *	2015-06-30	2017-12-19	昆明医科大学	一种含有缬沙坦的固体药物组合物
US20210267908A1 (en) *	2020-03-02	2021-09-02	Mankind Pharma Ltd.	Pharmaceutical compositions of rivaroxaban
CN112098408B (zh) *	2020-09-14	2022-12-09	湖北亿纬动力有限公司	一种羧甲基纤维素钠溶解效果的检测方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH30484A (en) *	1990-02-19	1997-05-28	Ciba Geigy	Acy compounds pharmaceutical composition containing said compound and method of use thereof
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
RU2271809C2 (ru)	1998-12-23	2006-03-20	Новартис Аг	Применение антагониста рецептора at-1 или модулятора рецептора ат-2 для лечения болезней, связанных с увеличением содержания рецепторов ат-1 или ат-2
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6211217B1 (en) *	1999-03-16	2001-04-03	Novartis Ag	Method for reducing pericardial fibrosis and adhesion formation
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
BR0110079A (pt) *	2000-04-12	2002-12-31	Novartis Ag	Combinação de compostos orgânicos
US6499984B1 (en) *	2000-05-22	2002-12-31	Warner-Lambert Company	Continuous production of pharmaceutical granulation
HK1052868A1 (zh)	2000-06-22	2003-10-03	Novartis Ag	药物组合物
SK287558B6 (sk) *	2000-07-19	2011-02-04	Novartis Ag	Soli valsartanu, ich použitie, spôsob ich výroby a farmaceutické prípravky obsahujúce tieto soli
US20030152622A1 (en) *	2001-10-25	2003-08-14	Jenny Louie-Helm	Formulation of an erodible, gastric retentive oral diuretic
JP4820056B2 (ja)	2002-01-17	2011-11-24	ノバルティスアーゲー	バルサルタンおよびｎｅｐ阻害剤を含む医薬組成物
JP2006511542A (ja) *	2002-12-18	2006-04-06	ノバルティスアクチエンゲゼルシャフト	バルサルタンとｃｏｘ−２インヒビターの組み合わせ
ES2238022T3 (es) *	2003-03-17	2008-11-01	Teva Pharmaceutical Industries Ltd.	Poliformos de valsartan.
EP1556363A2 (en)	2003-04-21	2005-07-27	Teva Pharmaceutical Industries Limited	Process for the preparation of valsartan and intermediates thereof
EP1618097A1 (en) *	2003-04-21	2006-01-25	Teva Pharmaceutical Industries Ltd	Process for the preparation of valsartan
US7915247B1 (en) *	2006-08-21	2011-03-29	Mutual Pharmaceutical Company, Inc.	Methods of use of fenofibric acid

2005
- 2005-12-23 EP EP08165631A patent/EP2033629B1/en not_active Revoked
- 2005-12-23 EA EA200900646A patent/EA015108B1/ru not_active IP Right Cessation
- 2005-12-23 CA CA002592091A patent/CA2592091A1/en not_active Abandoned
- 2005-12-23 RS RS20120564A patent/RS52607B/sr unknown
- 2005-12-23 US US11/794,039 patent/US20080102120A1/en not_active Abandoned
- 2005-12-23 PL PL08165631T patent/PL2033629T3/pl unknown
- 2005-12-23 ES ES08165631T patent/ES2397552T3/es active Active
- 2005-12-23 ME MEP-2012-149A patent/ME01453B/me unknown
- 2005-12-23 CN CN2005800447851A patent/CN101087589B/zh not_active Expired - Fee Related
- 2005-12-23 AU AU2005318365A patent/AU2005318365B2/en not_active Ceased
- 2005-12-23 WO PCT/EP2005/013963 patent/WO2006066961A1/en not_active Ceased
- 2005-12-23 SI SI200531638T patent/SI2033629T1/sl unknown
- 2005-12-23 EA EA200701107A patent/EA012392B1/ru not_active IP Right Cessation
- 2005-12-23 PT PT81656316T patent/PT2033629E/pt unknown
- 2005-12-23 DK DK08165631.6T patent/DK2033629T3/da active
- 2005-12-23 EP EP20050824409 patent/EP1833464A1/en not_active Withdrawn
2007
- 2007-07-24 NO NO20073889A patent/NO20073889L/no not_active Application Discontinuation
2013
- 2013-01-16 HR HRP20130033TT patent/HRP20130033T1/hr unknown

Also Published As

Publication number	Publication date
CA2592091A1 (en)	2006-06-29
EA200701107A1 (ru)	2008-04-28
CN101087589B (zh)	2013-01-30
EP2033629B1 (en)	2012-11-14
EP1833464A1 (en)	2007-09-19
EA015108B1 (ru)	2011-06-30
CN101087589A (zh)	2007-12-12
ES2397552T3 (es)	2013-03-07
EA012392B1 (ru)	2009-10-30
EA200900646A1 (ru)	2009-10-30
EP2033629A1 (en)	2009-03-11
AU2005318365B2 (en)	2011-02-03
NO20073889L (no)	2007-09-24
SI2033629T1 (sl)	2013-01-31
DK2033629T3 (da)	2013-02-04
US20080102120A1 (en)	2008-05-01
WO2006066961A1 (en)	2006-06-29
PL2033629T3 (pl)	2013-04-30
AU2005318365A1 (en)	2006-06-29
PT2033629E (pt)	2013-01-24
HRP20130033T1 (hr)	2013-02-28
RS52607B (sr)	2013-04-30

Publication	Publication Date	Title
IL223545A0 (en)	2013-02-03	Pharmaceutical compositions
ZA200700030B (en)	2009-06-24	Pharmaceutical compositions
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
GB0408308D0 (en)	2004-05-19	Pharmaceutical compositions
ZA200708705B (en)	2009-12-30	Pharmaceutical composition
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
ZA200705131B (en)	2008-06-25	Solid pharmaceutical composition comprising valsartan
SI2033629T1 (sl)	2013-01-31	Trden farmacevtski sestavek, ki obsega valsartan
PL1837019T3 (pl)	2013-02-28	Kompozycja farmaceutyczna rozpadająca się w ustach
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
EP1805154A4 (en)	2009-11-25	PHARMACEUTICAL COMPOSITIONS
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
ZA200700844B (en)	2009-07-29	Quinolone-containing medicinal composition
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
GB0407351D0 (en)	2004-05-05	Pharmaceutical compositions
GB0400971D0 (en)	2004-02-18	Pharmaceutical compositions
GB0502792D0 (en)	2005-03-16	Pharmaceutical compositions
GB0411502D0 (en)	2004-06-23	Pharmaceutical compositions
GB0402799D0 (en)	2004-03-10	Pharmaceutical composition
GB0425259D0 (en)	2004-12-15	Pharmaceutical composition
GB0425256D0 (en)	2004-12-15	Pharmaceutical composition
GB0422572D0 (en)	2004-11-10	Pharmaceutical compositions
GB0425728D0 (en)	2004-12-22	Pharmaceutical compositions